Trials / Recruiting
RecruitingNCT02139020
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will collect plasma samples at baseline, during treatment, and at progression.
Detailed description
In this study, the investigators will collect plasma samples at baseline, during treatment, and at progression. This plasma bank will be used to study the potential value of some biomarkers to predict treatment activity or resistance to cetuximab or other targeted agents
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Plasma samples | Plasma samples at baseline (and one whole blood sample) and at every radiological evaluations |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2033-01-01
- Completion
- 2033-01-01
- First posted
- 2014-05-15
- Last updated
- 2023-12-11
Locations
5 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02139020. Inclusion in this directory is not an endorsement.